Aricept Complexed with Acetylcholinesterase (Italian)
From Proteopedia
(Difference between revisions)
m |
|||
| (11 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| - | + | <StructureSection load='1eve' size='350' side='right' scene='29/2908/1eve_e20_cartoon/1' caption=''> | |
| - | + | ||
| - | + | ||
| - | + | ||
[[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | [[Image:E2020_interactins_in_AChE_gorge.jpg|left|250px]]<br /> | ||
| - | |||
| - | {{STRUCTURE_1eve| PDB=1eve | SCENE=Main_Page/E2020_in_ache_spinning/1 }} | ||
| - | |||
'''Struttura 3D del medicinale anti-Alzheimer, Aricept, in complesso con l'acetylcholinesterase,''' | '''Struttura 3D del medicinale anti-Alzheimer, Aricept, in complesso con l'acetylcholinesterase,''' | ||
(vedere anche [[AChE bivalent inhibitors (Part II)]]) | (vedere anche [[AChE bivalent inhibitors (Part II)]]) | ||
| Line 20: | Line 14: | ||
==A proposito di questa Struttura== | ==A proposito di questa Struttura== | ||
1EVE è una struttura di [http://en.wikipedia.org/wiki/Protein proteina sola] di sequenza di [http://en.wikipedia.org/wiki/Torpedo_californica Torpedo californica] con NAG ed E20 come [http://en.wikipedia.org/wiki/ligands ligands]. Attiva come [[Acetylcholinesterase]] col numero EC [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.1.7 3.1.1.7]. Dalle informazioni cristallografiche completi sono disponibili su [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1EVE OCA]. | 1EVE è una struttura di [http://en.wikipedia.org/wiki/Protein proteina sola] di sequenza di [http://en.wikipedia.org/wiki/Torpedo_californica Torpedo californica] con NAG ed E20 come [http://en.wikipedia.org/wiki/ligands ligands]. Attiva come [[Acetylcholinesterase]] col numero EC [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.1.1.7 3.1.1.7]. Dalle informazioni cristallografiche completi sono disponibili su [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1EVE OCA]. | ||
| - | + | </StructureSection> | |
==Riferimento== | ==Riferimento== | ||
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=10368299 10368299] | ||
| - | + | [[ar:Aricept_Complexed_with_Acetylcholinesterase (Arabic)]] | |
| + | [[ca:Aricept_Complexed_with_Acetylcholinesterase (Catalan)]] | ||
| + | [[zh:Aricept_Complexed_with_Acetylcholinesterase (Chinese)]] | ||
| + | [[cs:Aricept_Complexed_with_Acetylcholinesterase (Czech)]] | ||
| + | [[de:Aricept_Complexed_with_Acetylcholinesterase (German)]] | ||
| + | [[en:Aricept_Complexed_with_Acetylcholinesterase]] | ||
| + | [[es:Aricept_Complexed_with_Acetylcholinesterase (Spanish)]] | ||
| + | [[fr:Aricept_Complexed_with_Acetylcholinesterase (French)]] | ||
| + | [[he:Aricept_Complexed_with_Acetylcholinesterase (Hebrew)]] | ||
| + | [[it:Aricept_Complexed_with_Acetylcholinesterase (Italian)]] | ||
| + | [[ru:Aricept_Complexed_with_Acetylcholinesterase (Russian)]] | ||
| + | [[sk:Aricept_Complexed_with_Acetylcholinesterase (Slovak)]] | ||
| + | [[vi:Aricept_Complexed_with_Acetylcholinesterase (Vietnamese)]] | ||
| + | [[tr:Aricept_Complexed_with_Acetylcholinesterase (Turkish)]] | ||
| + | |||
[[Category: Acetylcholinesterase]] | [[Category: Acetylcholinesterase]] | ||
[[Category: Single protein]] | [[Category: Single protein]] | ||
| Line 40: | Line 48: | ||
[[Category: neurotransmitter cleavage]] | [[Category: neurotransmitter cleavage]] | ||
[[Category: serine hydrolase]] | [[Category: serine hydrolase]] | ||
| - | |||
| - | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Thu Nov 8 12:39:55 2007'' | ||
Current revision
| |||||||||||
Riferimento
Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs., Kryger G, Silman I, Sussman JL, Structure. 1999 Mar 15;7(3):297-307. PMID:10368299
Proteopedia Page Contributors and Editors (what is this?)
Jaime Prilusky, Fred Vellieux, Michal Harel, Alexander Berchansky, Eran Hodis, Joel L. Sussman
